OHLCX Market Research
Delayed

BIO

Biogen Inc. is a biotechnology company focused on developing therapies for neurological diseases, including multiple sclerosis and spinal muscular atrophy.

−8.60 (−2.34%) Nov 20, 2026 16:01 ET Delayed
Open
356.70
High
369.44
Low
353.31
Prev close
367.50
Volume
174K
Avg vol 10
285K

Today · Market closed · opens Mon 9:30 AM

Price

BIO chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 358.90

Strong sellNeutralStrong buy
Sell
score −0.22 · 18 signalling
2Buy
10Neutral
6Sell

Leaning sell. 6 of 18 signals point down against 2 up, carried by momentum and trend. Volatility is mostly neutral. Volume is mostly neutral. Stochastic, Williams %R and CCI sit in oversold territory. Trend strength is weak (ADX 14).

How to read this →

Trend

MACD 12, 26, 9
Below signal line and zero
MACD −1.73 · Signal 0.24 · Hist −1.97
Sell
ADX 14
Weak trend, −DI ahead
ADX 13.63 · +DI 23.44 · −DI 30.08
Neutral
Parabolic SAR 0.02, 0.2
Above price, 33.58 over the close
392.48
Sell
Ichimoku 9, 26, 52
Price below cloud, conversion above base
Conv 371.88 · Base 371.01 · A 371.82 · B 360.77
Neutral

Momentum

RSI 14
Mid-range, no extreme
42.90
Neutral
Stoch 14, 3
Oversold, %K just crossed under %D
%K 15.97 · %D 31.50
Neutral
Stoch RSI 14, 14, 3, 3
Low, %K still above %D
%K 29.41 · %D 23.40
Neutral
Williams %R 14
Oversold zone, falling
−84.03
Neutral
CCI 14
Below −100, still falling
−100.77
Neutral
MFI 14
Above midpoint, not overbought
60.16
Neutral
ROC 12
Price down 5.55% over 12 bars
−5.55%
Sell
AO 5, 35
Below zero and falling
−5.35
Sell
TRIX 18
Just above zero
0.023
Buy
KST 10/15/20/30, 3
Below its signal line
KST 6.77 · Signal 10.93
Sell

Volatility

Bollinger 20, 2
Lower half, %b 0.10
Up 392.76 · Mid 373.97 · Low 355.18
Neutral
Keltner 20, 10, 1.5
Inside the channel, lower half
Up 389.34 · Mid 370.12 · Low 350.89
Neutral

Volume

VWAP 345-bar
Close 17.3% above VWAP
305.86
Buy
Force Index 1
Negative, sellers in control
−1.6M
Sell
ATR
12.70
3.54% of close
A/D Line
4.3M
cumulative
OBV
267.5K
cumulative
Volume Profile
293.69 – 305.09
POC · bull 14.5M · bear 10.8M · 57 / 43
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

-1.27%

Change in value over the past month.

3 month return

-5.99%

Change in value over the last three months.

Max drawdown

25.74%

Largest fall from a peak to the low that followed.

Standard deviation

37.49%

How far daily returns stray from their average, annualised.

Sharpe ratio

0.67

Return above the risk-free rate per unit of volatility.

Calmar ratio

0.98

Annualised return against the maximum drawdown.

About

BIO summary

Loading summary…

Questions

BIO, answered

What is Biogen’s role in the Alzheimer’s disease community?

Biogen plays a significant role in the Alzheimer’s disease community by developing potential treatments and supporting research efforts.

Where is Biogen headquartered?

Biogen is headquartered in Cambridge, Massachusetts, USA.

How can I find information about Biogen’s clinical trials?

Information about Biogen’s clinical trials can be found on their website and through clinical trial registries.

Is Biogen involved in research and development?

Yes, Biogen invests heavily in research and development to discover and develop new therapies for neurological conditions.

What is Biogen’s commitment to sustainability?

Biogen is committed to sustainability and aims to reduce its environmental impact through various initiatives, including reducing greenhouse gas emissions.

What is the stock performance of Biogen?

You can check Biogen’s stock performance on financial news websites and stock market platforms.

How can I access Biogen’s financial reports?

Biogen’s financial reports are available on their investor relations website, including quarterly and annual reports.

How can I stay updated on Biogen’s news?

You can stay updated on Biogen’s news by subscribing to their newsletter and following them on social media.

Does Biogen have any partnerships?

Biogen collaborates with various academic and industry partners to advance its research and development efforts.

How can I contact Biogen investor relations?

You can contact Biogen investor relations through their official website for inquiries related to the company’s financial performance.

News

BIO in the news

Maximize Your BIO Trading Now

Empower your trading with OHLCX execution platform. Our comprehensive platform delivers precise analysis and strategic insights for BIO, designed to improve your trading outcomes. Boost your investment success with us and unlock new opportunities with our advanced system!

Experience Excellence Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.